Compare DGX & BWXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DGX | BWXT |
|---|---|---|
| Founded | 1967 | 1867 |
| Country | United States | United States |
| Employees | N/A | 8700 |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.5B | 18.8B |
| IPO Year | 1996 | N/A |
| Metric | DGX | BWXT |
|---|---|---|
| Price | $185.07 | $210.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | $196.69 | ★ $202.93 |
| AVG Volume (30 Days) | 1.0M | ★ 1.1M |
| Earning Date | 02-10-2026 | 02-23-2026 |
| Dividend Yield | ★ 1.73% | 0.49% |
| EPS Growth | ★ 14.49 | 10.60 |
| EPS | ★ 8.51 | 3.34 |
| Revenue | ★ $10,850,000,000.00 | $3,058,850,000.00 |
| Revenue This Year | $12.37 | $19.06 |
| Revenue Next Year | $3.54 | $16.40 |
| P/E Ratio | ★ $21.73 | $61.69 |
| Revenue Growth | 13.74 | ★ 14.01 |
| 52 Week Low | $157.20 | $84.21 |
| 52 Week High | $197.55 | $220.57 |
| Indicator | DGX | BWXT |
|---|---|---|
| Relative Strength Index (RSI) | 55.56 | 58.65 |
| Support Level | $182.36 | $201.10 |
| Resistance Level | $187.12 | $219.85 |
| Average True Range (ATR) | 3.69 | 8.89 |
| MACD | 0.19 | -0.85 |
| Stochastic Oscillator | 48.68 | 46.05 |
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.